Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Vaccine strain rSHA-[delta]200, and construction method and application thereof

A construction method and vaccine strain technology, applied in the field of vaccine strain rSHA-△200 and its construction, can solve problems such as virus mutation

Active Publication Date: 2019-01-25
YANGZHOU UNIV +1
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] In order to solve the problem of continuous mutation of the existing H9 subtype AIV virus, the present invention provides a vaccine strain rSHA-△200 with strong immunity and good cross-immunity of H9 subtype AIV

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Vaccine strain rSHA-[delta]200, and construction method and application thereof
  • Vaccine strain rSHA-[delta]200, and construction method and application thereof
  • Vaccine strain rSHA-[delta]200, and construction method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0085] 1. Hemagglutination test to screen candidate vaccine strains

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a vaccine strain rSHA-[delta]200, and a construction method and application thereof, relates to that field of influenza vaccine. The vaccine strain rSHA-[delta]200 includes a HAgene that does not contain an NRT glycosylation site. The invention finds out the potential glycosylation sites on the HA protein through analysis, deletes glycosylation sites by site-directed mutagenesis technology, constructs HA expression plasmids with multiple glycosylation sites deleted, obtains recombinant vaccine strains by using 8 plasmid reverse genetic technology, and prepares antiserum. The rSHA-[delta]200 obtained in the invention is an ideal candidate for inactivated vaccine against H9 subtype AIV because of its good cross-immunity and serum cross-neutralization ability.

Description

technical field [0001] The invention relates to the technical field of influenza vaccines, in particular to a vaccine strain rSHA-Δ200 and its construction method and application. Background technique [0002] H9 subtype AIV is usually low-pathogenic avian influenza, which causes low poultry mortality. However, due to its wide distribution and fast transmission speed, the egg production of laying hens will drop sharply after infection, and broiler chickens will grow slowly. Reducing the feed-to-meat ratio has caused huge economic losses to the poultry farming industry. H9 subtype AIV infection is likely to lead to a sharp decline in the poultry's own immunity, resulting in concurrent or secondary infections of other bacteria or viruses leading to increased mortality. The H9 subtype AIV will also serve as the donor of the internal genes of other subtype influenza viruses, providing conditions for the generation of new influenza virus strains, triggering the outbreak of new i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N7/01C12N15/85A61K39/295A61K39/145A61P31/16C12R1/93
CPCA61K39/12A61K2039/5252A61K2039/552A61K2039/70A61P31/16C12N7/00C12N15/85C12N2760/16121C12N2760/16134C12N2760/16152
Inventor 彭大新石宝兰陈素娟张伟秦涛王泽源乔依漪苏湘李卓恬沈海峰刘雷
Owner YANGZHOU UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com